CHICAGO — The split between Dana-Farber Cancer Institute and Mass General Brigham has been messy.
Some people who don’t see breakups coming wonder what went wrong, and maybe channel the sorrow into a love ballad. But Mass General Brigham is taking a different tack — it’s simply getting over it.
The $20 billion nonprofit hospital system is now plotting out how its cancer programs will look in a post-Dana-Farber world.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.
Already have an account? Log in
Already have an account? Log in
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect